About TRIP
Tracking Research in Psychedelics
Our Mission
TRIP is a public data infrastructure project that aggregates, enriches, and organizes scholarly literature on psychedelic compounds. Our goal is to make psychedelic research more accessible to scientists, clinicians, policymakers, and the public.
What We Track
We currently track 37,973 research papers across 36 psychedelic compounds:
General
16,130 papers
Ketamine
9,336 papers
MDMA
3,528 papers
LSD
2,990 papers
Psilocybin
2,089 papers
Ayahuasca
866 papers
DMT
745 papers
Ibogaine
702 papers
Mescaline
619 papers
Salvia
496 papers
Polysubstance
375 papers
2C-B
62 papers
Dextromethorphan
4 papers
Salvinorin a
4 papers
2c-e
2 papers
Cannabis
2 papers
Dpt
2 papers
Salvinorin
2 papers
Scopolamine
2 papers
25b-nboh
1 papers
25b-nbome
1 papers
2c-i
1 papers
2c-p
1 papers
4-aco-dipt
1 papers
4-aco-dmt
1 papers
5-meo-dipt
1 papers
5-MeO-DMT
1 papers
Bufotenine
1 papers
Buspirone
1 papers
Cabergoline
1 papers
Ephedrine
1 papers
Ketamine, dextromethorphan
1 papers
Lidocaine
1 papers
Lisuride
1 papers
Phencyclidine
1 papers
Venlafaxine
1 papers
How It Works
- 1
Discover
We scan OpenAlex, PubMed, and Google Scholar daily for new papers.
- 2
Enrich
Each paper is enriched with metadata from Crossref including authors, journal, citations, and abstracts.
- 3
Classify
AI-powered classification extracts study type, species, neuroimaging methods, and key findings from each paper.
- 4
Store & Serve
Papers are stored in our database and made searchable through this interface.
Contact
Have questions, suggestions, or want to collaborate? We'd love to hear from you.
tripforscience@gmail.comBuilt by Brock Pluimer, PhD